Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Like Early Pipeline but Risk/Reward not Favorable
Tweet Send to a FriendGet Alerts BMRN Hot Sheet
Price: $65.76 +0.32%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade BMRN Now!
Deutsche Bank downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Buy to Hold. PT $27.
Deutsche analyst says, "Top-line results from the ph 2 trial of daily PEG-PAL will provide much needed color on the tolerability profile, which has not fared well at once weekly (high discontinuation rates). Data is expected in mid-2011. We currently assign 50% probability of success to PEG-PAL. If we remove PEG-PAL, our valuation is $24 (-$3) & if we assign 100% probability of success, our valuation increases to $31 (+$4). We view the risk/reward as unfavorable given the past PEG-PAL data."
For more ratings news on BioMarin Pharmaceutical Inc. click here and for the rating history of BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $28.29 yesterday, with a 52 week range of $17.70-$28.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Deutsche analyst says, "Top-line results from the ph 2 trial of daily PEG-PAL will provide much needed color on the tolerability profile, which has not fared well at once weekly (high discontinuation rates). Data is expected in mid-2011. We currently assign 50% probability of success to PEG-PAL. If we remove PEG-PAL, our valuation is $24 (-$3) & if we assign 100% probability of success, our valuation increases to $31 (+$4). We view the risk/reward as unfavorable given the past PEG-PAL data."
For more ratings news on BioMarin Pharmaceutical Inc. click here and for the rating history of BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $28.29 yesterday, with a 52 week range of $17.70-$28.42.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- Standpoint Research Downgrades Delta Air Lines (DAL) to Hold
- RBC Capital Downgrades Blue Nile (NILE) to Sector Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
